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Targeted determination of new psychoactive substances, drugs of 
abuse, psychoactive pharmaceuticals and other biomarkers in 
wastewater by LC-Q-ToF- HRMS
Sign hanging in Einstein‟s office at Princeton
“Not everything that counts can be counted, 
and not everything that can be counted counts” 
As Daughton‟s paraphrases very clearly demonstrated 
„„Not everything that can be measured is worth measuring, 
and not everything worth measuring is measurable‟‟ 
Emerging Pollutants (EPs)
• Pesticides
• Pharmaceuticals
• Illicit drugs
• Personal care products
• Endocrine disruptive 
compounds (EDCs)
• Flame retardants
• Food additives
• Disinfection by-products 
+
Metabolites     &
Transformation Products 
(TPs)
> pesticides
> pharmaceuticals, illicit, DoA
> steroids & doping compounds
 industrial chemicals, food additives, 
dyes 
 naturally occurring compounds 
(amino acids, neurotransmitters)
> metabolites & TPs
database of 2327 EPs
Wastewater:
Potentially tens of 
thousands of substances
Location: WWTP of Athens, Greece
(Residential population: 3,700,000 – Mean flow rate: 766,000 m3 day-1 -
dewatered sludge production: 530,000 kg day-1)
Period: December 2010 - March 2015
Samples: 24-h composite flow-proportional samples of influent wastewaters
& effluent wastewaters (7 consecutive days)
2-h composite flow-proportional samples of influent wastewater
(Thursday & Saturday, 12 samples per day, from 02:00 to 00:00)
Sampling
Sample Preparation
 100 mL wastewater (GFF filtration)
 IS spiking (100 ng/L)
 SPE           Mixed-bed cartridges
 Extraction: Neutral, Basic & Acidic Compounds
Strata-X
Mixture:
Strata-XCW,
Strata-XAW,
ENVI+
*Kern et al. EST 
(2009) 43(18):7039
Strata-X
Strata-XCW
Strata-XAW
ENVI+
for neutral & aromatic compounds
for basic compounds (pKa≈4.5)
for acidic compounds 
(pKa≈9)
for polar 
compounds Elution step
MeOH: ethyl acetate (1:1)
• 2% NH3
• 1.7% formic acid
Column: Acclaim RSLC 120 C18 2.2 μm, 2.1 × 100 mm 
Pre-column: VanGuard (Waters): Acquity UPLC BEH C18 1.7 μm, 2.1 × 5 mm 
 20 min chromatogram
 Gradient elution program in 
the M.P. 
 Gradient elution program in
the flow rate
 Positive & Negative ESI
 bbCID mode
(MS & MS/MS 
simultaneously)
MaXis Impact
Ultra High Resolution
Time-of-Flight Mass 
Spectrometer
Instrumentation
 Retention time
 Molecular Formula
 Adducts
 In-source fragments
 bbCID fragments
 Ion Ratios
Database
Optimization of the evaluation method
validation dataset 
 195 compounds
 10% of the compounds of the total database
 Representative retention time
 Representative physicochemical properties
 Representative ionization behavior
 Compounds from every class of EPs
Screening method:
The method used to identify 
the non-compliant samples 
(true positive) with a β-error 
less than 5%
C spiked 
samples 
(μg/L)
% ‘missed 
compounds 
due to Area 
/ Intensity 
threshold
False 
Negative 
results
(compounds)
Successful 
Identification 
Rate (%)
1 0 1 99
0.5 0 2 99
0.25 1.3 2 97
0.05 3.3 3 95
0.025 5.2 5 92
Optimization - Validation
Area 1000 (+) / 600 (-)
Intensity 250 (+) / 150 (-)
ret. Time ΔRT (min) 0,4
accuracy (ppm) 5
mSigma threshold 200
Successful Identification 
Rate >95%
61 (/195) 
compounds of interest
% Recoveries % Matrix Effect
91.7 % analytes 
signal 
suppression
8.3 % analytes 
signal 
enhancement
% Repeatability (n=6)
94.5 % analytes 
<20% RSD
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Validation Results
Results
Effluent wastewaters:
301 compounds
Influent wastewaters:
338 compounds
371 compounds detected
• 61 pesticides 
• 205 licit & illicit drugs
• 4 sweeteners
• 10 PFCs
• 8 Amino acids
• 47 TPs
• 51 pesticides
• 191 licit & illicit drugs
• 4 sweeteners
• 11 PFCs
• 4 Amino acids
• 49 TPs
Results
 Drugs
Metformin →most abundant Benzoylecgonine: 0.38 μg/L 
Haloperidol → less abundant Cocaine – EME: 0.24 μg/L
Influent: 0.14 ng/L - 93 μg/L THCA: 0.31 μg/L
Effluent: 0.5 ng/L - 35 μg/L
 Opiates, Opioids
Influent: 5 compounds (Morphine 0.64 μg/L – EDDP 0.12 μg/L)
Effluent: 6 compounds (degradation to metabolites: Norcodeine-Hydrocodone)
 Stimulants- Amphetamines 
AMP, MA, MDA, MDMA, MDEA
2,5-dimethoxy-4-methylphenethylamine (2C-D), Dimethoxyamphtamine, 
Trimethoxyamphtamine, Ethylamphetamine, Dimethylamphetamine, 
para-Methoxy-N-methylamphetamine (PMMA)
4'-Methyl-α-pyrrolidinopropiophenone (MPPP) 
Cathine, Aminorex, Phendimetrazine
Mephentermine, Midodrine, Heptaminol
Bemegride, Pemoline
 Pesticides
Fluometuron, Azoxystrobin & Dimethachlor met.
Influent: 0.3 ng/L- 2.04 μg/L
Effluent: 0.2 ng/L- 13.6 μg/L
 Sweeteners
Influent: 0.6 μg/L sucralose - 24 μg/L cyclamate
Effluent: removal >60 %
 Other chemicals
Benzoic acid: 49 μg/L (influent) - 29 μg/L (effluent) 
Ethyl sulfate: 10.6 μg/L (influent) – 3.3 μg/L (effluent) 
 Amino acids – Neurotransmitters 
Influent: Conc. >2 μg/L (8 AAs) - Valine: most abundant (58 μg/L)
Effluent: significant removal rates (4 AAs), Val & GABA > 10 μg/L 
66 pesticides
in total
 Sympathomimetics: Ephedrine, Norephedrine, Etafedrine
 Antidepressants: SSRIs, SNRIs, TCAs, MAOIs (Phenelzine)
 Benzodiazepines (Oxazepam)
 Antiepileptics –Barbiturates– Anesthetics 
 Antipsychotics (Clozapine)
Results
Daily Variation over a Week of 
Carbamazepine & its metabolites
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Changes over the years


3 dimethyl-xanthines:
Paraxanthine
Theobromine
Theophylline
Results
Caffeine
& its metabolites
6.5 g caffeine /day/ 
1000 inhibitants
EFSA guideline:
<200 mg/day
Caffeine >
Paraxanthine > Theophylline
Intra-day trendIntra-week trend
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Nicotine
& its metabolites
Results
Cotinine
Hydroxy-cotinine
Daily loadings 
of metabolites
Nicotine 
equivalents 
(excretion rates)
Number of cigarettes
Number of smokers
(21.4 % population, age >15)
Number of inhabitants 
estimated
13.6 millions 
daily in Athens 640,000
in Athens
~3.05 millions
Not completely 
accurate due to 
other sources of 
nicotine !0
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Castiglioni et al, 
Tob. Control, 2015
Results
Nucleosides
Components of DNA & RNA
health stressors & 
human health endpoints
Suspect Screening
 Adenosine
 Deoxy- Adenosine
 Deoxy-Guanosine
 N-Methyl-Guanosine
 7-Methyl-Guanosine
 Cytidine
Amino acids
Neurotransmitters
Steroids
THE, THF
Same trend over the week
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Results Daily Variations over a Week
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Results
2 C-D
2-(2,5-dimethoxy-4-
methylphenyl)ethanamine
Bemegride
Supporting measure in 
treating depressant overdose
Daily Variation over a Week
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Results Daily Variations over a Week
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
Mon, 
10/03
Tue, 
11/03
Wed, 
12/03
Thu, 
13/03
Fri, 
14/03
Sat, 
15/03
Sun, 
16/03
lo
a
d
s
 (
k
g
/d
a
y
)
Phenelzine
Phenelzine
0
50
100
150
200
250
300
350
400
450
Mon, 
10/03
Tue, 
11/03
Wed, 
12/03
Thu, 
13/03
Fri, 
14/03
Sat, 
15/03
Sun, 
16/03
lo
a
d
s
 (
g
/d
a
y
)
Benzoylecgonine 
(BECG)
Ephedrine
0
10
20
30
40
50
60
70
Mon, 10/03Tue, 11/03Wed, 12/03Thu, 13/03Fri, 14/03Sat, 15/03Sun, 16/03
lo
a
d
s
 (
g
/d
a
y
)
Amisulpride
Buspirone 
PMMA (para-Methoxy-N-
methylamphetamine)
0
1
2
3
4
5
6
7
Mon, 10/03Tue, 11/03Wed, 12/03Thu, 13/03Fri, 14/03Sat, 15/03Sun, 16/03
lo
a
d
s
 (
g
/d
a
y
)
Ethylamphetamine
Mephentermine 
Results Intra-Day Variation 
on the Weekend (15/03) & on Weekday (12/03)
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Conclusions
 Wide-scope target screening methods are useful: The wider, the better
 In-house database with 2327 compounds, 
including 745 NPS, DoA, PP & metabolites 
 Possibility for biomarkers search in one method after statistical analysis
 Retrospective analysis - Continuously increasing database 
 Possibility for Suspect & Non-target Screening
This research has been co-financed by the European Union and Greek national funds 
through the Operational Program "Education and Lifelong Learning" of the National 
Strategic Reference Framework (NSRF) ARISTEIA 624 (TREMEPOL project).
http://trams.chem.uoa.gr/
Acknowledgments  
Anna Bletsou
Viola Borova
Pablo Gago-Ferrero
Thank you for your attention!
